4/23
07:00 am
radx
Radiopharm Theranostics Reports Business Update
Medium
Report
Radiopharm Theranostics Reports Business Update
4/20
07:00 am
radx
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
Medium
Report
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
4/8
07:00 am
radx
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Medium
Report
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
4/7
07:00 am
radx
Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
Low
Report
Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
3/27
07:00 am
radx
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer
Low
Report
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer
3/25
04:43 am
radx
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study [Yahoo! Finance]
Medium
Report
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study [Yahoo! Finance]
3/25
03:47 am
radx
Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks [Yahoo! Finance]
Medium
Report
Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks [Yahoo! Finance]
3/24
07:00 am
radx
Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
High
Report
Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
2/24
07:30 am
radx
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
Low
Report
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
2/2
02:57 pm
radx
RADX Fiscal 1H:26 Activity and Cash Flows [Yahoo! Finance]
Medium
Report
RADX Fiscal 1H:26 Activity and Cash Flows [Yahoo! Finance]
1/28
07:00 am
radx
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
Low
Report
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
1/24
12:30 am
radx
Radiopharm Theranostics (NASDAQ:RADX) was downgraded by analysts at
Wall
Low
Report
Radiopharm Theranostics (NASDAQ:RADX) was downgraded by analysts at
Wall